PMID: 8962095Dec 10, 1996Paper

Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system

Proceedings of the National Academy of Sciences of the United States of America
P KahlemP Djian

Abstract

Many proteins contain reiterated glutamine residues, but polyglutamine of excessive length may result in human disease by conferring new properties on the protein containing it. One established property of a glutamine residue, depending on the nature of the flanking residues, is its ability to act as an amine acceptor in a transglutaminase-catalyzed reaction and to make a glutamyl-lysine cross-link with a neighboring polypeptide. To learn whether glutamine repeats can act as amine acceptors, we have made peptides with variable lengths of polyglutamine flanked by the adjacent amino acid residues in the proteins associated with spinocerebellar ataxia type 1 (SCA1), Machado-Joseph disease (SCA3), or dentato-rubral pallidoluysian atrophy (DRPLA) or those residues adjacent to the preferred cross-linking site of involucrin, or solely by arginine residues. The polyglutamine was found to confer excellent substrate properties on any soluble peptide; under optimal conditions, virtually all the glutamine residues acted as amine acceptors in the reaction with glycine ethyl-ester, and lengthening the sequence of polyglutamine increased the reactivity of each glutamine residue. In the presence of transglutaminase, peptides containing polyglu...Continue Reading

References

Sep 9, 1977·Biochemical and Biophysical Research Communications·P J BirckbichlerM K Patterson
Dec 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C S GreenbergR H Rice
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K N ParameswaranL Lorand
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P Djian, H Green
Feb 1, 1986·Journal of Neurochemistry·A PastuszkoM Erecińska
Aug 15, 1986·Cell·R L Eckert, H Green
Dec 8, 1972·Annals of the New York Academy of Sciences·S I Chung
Jul 1, 1968·Archives of Biochemistry and Biophysics·J H Pincus, H Waelsch
Mar 1, 1969·Biochimica Et Biophysica Acta·H Toda, J E Folk
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D J SelkoeY Ihara
Jan 1, 1984·Molecular and Cellular Biochemistry·L Lorand, S M Conrad
Jan 1, 1995·Trends in Neurosciences·R L Albin, D A Tagle
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·K StottM Perutz
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·H Green, N Wang
Jan 1, 1994·Somatic Cell and Molecular Genetics·Christine M AmbroseMarcy E MacDonald
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M F PerutzJ T Finch
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·S Karlin, C Burge
Jan 1, 1995·Annual Review of Genetics·C T Ashley, S T Warren

❮ Previous
Next ❯

Citations

Aug 24, 2010·EMBO Molecular Medicine·Parsa Kazemi-Esfarjani, Albert R La Spada
Aug 31, 2000·Molecular Neurobiology·X J Li
Aug 1, 2000·Indian Journal of Clinical Biochemistry : IJCB·K T Shetty, R Christopher
Sep 26, 2006·Journal of Neurology·Lindsay R PattisonRaphael M Bonelli
Jul 4, 2008·Amino Acids·Angelo Facchiano, Francesco Facchiano
Aug 22, 2003·Current Neurology and Neuroscience Reports·Penelope Hogarth
Jul 27, 2011·Journal of Molecular Neuroscience : MN·Lars DolgeWerner Baumgartner
Jun 27, 2013·Biochemical and Biophysical Research Communications·Wen-Juan GuanJun-Ling Wang
Aug 15, 2000·Trends in Neurosciences·J H Cha
May 14, 1999·Trends in Neurosciences·P B Tran, R J Miller
Dec 12, 2001·Neurochemistry International·Arthur J L CooperJohn P Blass
Dec 12, 2001·Neurochemistry International·Mathieu LesortGail V W Johnson
Dec 12, 2001·Neurochemistry International·Marcela V KarpujLawrence Steinman
Dec 12, 2001·Neurochemistry International·Soo Youl KimPeter M Steinert
Jul 11, 2002·Biochimie·Guylaine Hoffner, Philippe Djian
Apr 5, 2000·Progress in Neurobiology·M LesortG V Johnson
Nov 24, 2001·Brain Research Bulletin·L Masino, A Pastore
Nov 24, 2001·Brain Research Bulletin·Y Kobayashi, G Sobue
Nov 24, 2001·Brain Research Bulletin·M RimoldiV Zimarino
Jun 1, 1997·Current Opinion in Cell Biology·P S Reddy, D E Housman
Mar 31, 1999·Trends in Biochemical Sciences·M F Perutz
May 2, 2001·The International Journal of Biochemistry & Cell Biology·K HitomiM Maki
Oct 30, 1998·Molecular Medicine Today·O RiessR Krüger
Aug 24, 2007·Analytical Chemistry·Bi-Huang HuPhillip B Messersmith
Oct 6, 2005·Nature Reviews. Genetics·Nicholas A Di Prospero, Kenneth H Fischbeck
Jun 26, 1999·Alimentary Pharmacology & Therapeutics·F BiagiP J Ciclitira
Apr 2, 2003·Psychiatry and Clinical Neurosciences·Masahiro HayashiHisakazu Furuta
May 3, 2011·The Journal of Biological Chemistry·Chiung-Yueh HsuMichel Simon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.